American Association of Neuromuscular & Electrodiagnostic Medicine

Cell Therapies Offer Hope But Are Often Misused

October 13, 2018

Cellular therapies have the potential to make a meaningful difference for patients with neurological disorders, if used correctly.

IncobotulinumtoxinA Reduces Sialorrhea Across Neurological Disorders

October 12, 2018

IncobotulinumtoxinA significantly reduced unstimulated salivary flow rate for patients with sialorrhea.

Patisiran Shows Sustained Improvements in Disease Progression for hATTR Amyloidosis

October 12, 2018

Patisiran maintained improvements in mNIS+7 and rapidly halted neurologic disease progression in hATTR amyloidosis.

Subcutaneous Immunoglobulin Effective Alternative to Intravenous for Myasthenia Gravis

October 11, 2018

Subcutaneous immunoglobulin is an effective and well-tolerated alternative to intravenous immunoglobulin for myasthenia gravis.

Eculizumab's Myasthenia Gravis Benefits Sustained in Long-Term Extension Study

October 11, 2018

Eculizumab showed sustained activity and tolerability through 3 years for generalized myasthenia gravis.